Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide,population-based cohort study

Chung-Mao Kao, Yen-Ju Chen, Yi-Ming Chen [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2021-5

Efficacy and Safety of conventional Synthetic,Biologic,and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis-Interstitial Lung Disease: A Narrative Review

Richard Conway, Luke Corcoran, Elena Nikiphorou

Indian Journal of Rheumatology

Open access

Research article

First published 2025

Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice

Leticia Leon, Dalifer Freites-Nuñez, Esther Toledano [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2020

An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision

Mariagrazia Lorenzin, Francesca Ometto, Augusta Ortolan [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2022

Cell-based therapies for rheumatoid arthritis: opportunities and challenges

Yu-Jing Li, Zhu Chen

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Review article

First published 2021-7

Host Modulation and Treatment of Periodontal Disease

M.G. Balta, E. Papathanasiou, I.J. Blix [...]

Journal of Dental Research

Open access

Research article

First published 2020-07

Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients

Theodore Mellors, Johanna B. Withers, Asher Ameli [...]

Network and Systems Medicine

Open access

Research article

First published 2021

Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents

Benjamin Fernandez-Gutierrez, Leticia Leon, Alfredo Madrid [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2022

Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure

Dong-Jin Park, Sung-Eun Choi, Ji-Hyoun Kang [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Review article

First published 2018-8

Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis

Eric G. Boyce, Edward L. Rogan, Deepti Vyas [...]

Annals of Pharmacotherapy

Search results